RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $287 Price Target

Benzinga Newsdesk www.benzinga.com Negative 94.0%

Neg 94% Neu 0% Pos 0%

RBC Capital analyst Shagun Singh reiterates Johnson & Johnson (NYSE:JNJ) with a Outperform and maintains $287 price target.